Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Teva Pharmaceuticals USA, Inc. et al v. Mylan Pharmaceuticals Inc. et al
Case Number:
1:09-cv-08824
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
June 25, 2012
Mylan, Sandoz Infringed Teva's MS Drug Patents, Judge Finds
In a major win for Teva Pharmaceutical Industries Ltd., a judge has ruled that Mylan Pharmaceuticals Inc. and Sandoz Inc. infringed the Israeli drugmaker's patents for Copaxone in making generic versions of the multiple sclerosis drug.
-
September 07, 2011
Teva's Copaxone Trial Kicks Off Against Mylan, Sandoz
An attorney for Mylan Pharmaceuticals Inc. told a New York federal judge Wednesday that its generic version of Teva Pharmaceutical Industries Ltd.'s multiple sclerosis drug Copaxone doesn't infringe several Teva patents.